Kheiron partnered with EMRAD 3 years ago and have been developing MIA since which is now a fully trained “CE” marked AI to spot Breast Cancer.
The aim of the project is for MIA to be the second reader speeding up the whole Breast Screening process.
MIA AI will be deployed in a Shadow Mode in REAL TIME environment in 6 stages.
MIA AI Benefits:
Helps with the critical decision – Recall or No - Recall
Will be used as a backup option when hospitals are short staffed
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. for more information